Abstract

Fenoldopam Mesylate Injection

Author(s): Allen Loyd V Jr

Issue: Jul/Aug 2010 - Sterile Compounding

Page(s): 340

Download in electronic PDF format for $75
  • Fenoldopam Mesylate Injection Page 1

Abstract

A formulation for preparing Fenoldopam Mesylate Injection. Includes ingredients, method of preparation, discussion, and references for the compounding pharmacist.

Related Keywords

  • formulation
  • fenoldopam mesylate
  • hypertension
  • high blood pressure
  • antihypertensive agent

Related Categories

  • FORMULATIONS
  • CARDIOLOGY
  • NEUROLOGY

Printer-Friendly Version

Related Articles from IJPC

Issue/Page
View/Buy		 Title/Author
(Click for Abstract / Details / Purchase)
Jul/Aug 2010
Pg. 340
Fenoldopam Mesylate Injection
Author(s): Allen Loyd V Jr
Jul/Aug 2001
Pg. 310-312
Wetting and/or Solubilizing Agents, Featured Excipient:
Author(s): Allen Loyd V Jr
Jan/Feb 2015
Pg. 69
Phentolamine Mesylate 5-mg/mL Injection
Author(s): Allen Loyd V Jr
Jul/Aug 2002
Pg. 255-256
Aminophylline 3%, Co-dergocrine Mesylate 0.05%, and Isosorbide Dinitrate 0.25% Cream for the Treatment of Orgasmic Dysfunction in Women
Author(s): Mason Dave
Mar/Apr 2015
Pg. 144
Deferoxamine Mesylate 213/mg/mL or 95-mg/mL Injection
Author(s): Allen Loyd V Jr
Nov/Dec 2013
Pg. 498
Benztropine Mesylate 1-mg/mL Injection
Author(s): Allen Loyd V Jr
Nov/Dec 2013
Pg. 503
Dihydroergotamine Mesylate 1-mg/mL Injection
Author(s): Allen Loyd V Jr
Jul/Aug 2016
Pg. 318
Dolasetron Mesylate 20-mg/mL Injection
Author(s): Allen Loyd V Jr
Jan/Feb 2000
Pg. 66-68
Stability of Alatrofloxacin Mesylate in 5% Dextrose Injection and 0.45% Sodium-Chloride Injection
Author(s): Gupta Vishnu D, Bailey RE
Mar/Apr 2005
Pg. 117-119
Combating Cardiovascular Disease With Compounded Medications. Part 1: Combination Cardiac Medicines to Control Blood Pressure
Author(s): Harrington Catherine A, Cauffield Jacintha
May/Jun 2007
Pg. 251
Trovafloxacin Mesylate 10-mg/mL Oral Liquid
Author(s): Allen Loyd V Jr
Sep/Oct 2018
Pg. 410
Pergolide Mesylate 0.2-mg/mL Oral Liquid, Veterinary
Author(s): Allen Loyd V Jr
May/Jun 2005
Pg. 201-205
Combating Cardiovascular Disease with Compounded Medications -- Part 2: Clinical and Compounding Issues for Antihypertensive Drugs
Author(s): Harrington Catherine A, Cauffield Jacintha
Sep/Oct 2008
Pg. 392-397
Transdermal Amlodipine Besylate in Lipoderm for the Treatment of Feline Hypertension: A Report of Two Cases
Author(s): Mixon William, Helms Scott R
Nov/Dec 2009
Pg. 572-573
Rapid, Simple Assay for Ziprasidone Mesylate in Extemporaneously Compounded Oral Solutions
Author(s): Parish Roy C
May/Jun 2009
Pg. 254-258
Stability of Pergolide Mesylate Oral Liquid at Room Temperature
Author(s): Shank Brandon R, Ofner Clyde M III
Nov/Dec 2021
Pg. 509
Ziprasidone Mesylate 2.5 mg/mL in Ora-Sweet Suspension
Author(s): Allen Loyd V Jr
Jul/Aug 2022
Pg. 270-274
A Compendium of Compounding Agents and Formulations, Part 4: Nifedipine and Pentoxifylline
Author(s): Riepl Mike
Jul/Aug 2014
Pg. 330
Propranolol Hydrochloride 1-mg/mL Injection
Author(s): Allen Loyd V Jr
Mar/Apr 2013
Pg. 153
Verapamil Hydrochloride 2.5-mg/mL Injection
Author(s): Allen Loyd V Jr